Unveiling intricating roles and mechanisms of ferroptosis in melanoma

Rui Tao1, Yichuan Li2, Song Gong3

  • 1Department of Plastic Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, China.

Insights

Ferroptosis, an iron-dependent cell death, shows promise in melanoma treatment. Understanding ferroptosis mechanisms and biomarkers can lead to new diagnostic and therapeutic strategies for this invasive cancer.

Area of Science:

  • Oncology
  • Cell Biology
  • Immunology

Background:

  • Melanoma, a malignant tumor of melanocytes, has a rising incidence.
  • Ferroptosis is a distinct form of programmed cell death driven by iron accumulation and lipid peroxidation.
  • Ferroptosis is morphologically characterized by mitochondrial alterations.

Purpose of the Study:

  • To review the role and regulatory mechanisms of ferroptosis in melanoma development.
  • To explore ferroptosis-related immune regulation in melanoma.
  • To discuss the diagnostic and therapeutic potential of ferroptosis in melanoma.

Main Methods:

  • Literature review of ferroptosis and melanoma research.
  • Analysis of ferroptosis biomarkers and their expression patterns in melanoma progression.
  • Examination of ferroptosis induction's impact on melanoma growth and immunotherapy.

Main Results:

  • Ferroptosis plays a significant role in regulating melanoma development.
  • Ferroptosis-associated biomarkers indicate tumor sensitivity and offer diagnostic/therapeutic targets.
  • Inducing ferroptosis inhibits melanoma growth and enhances immunotherapy efficacy.

Conclusions:

  • Ferroptosis is a key regulator in melanoma, with implications for diagnosis and treatment.
  • Ferroptosis-based therapies offer novel strategies for melanoma management.
  • Further research into ferroptosis mechanisms will advance melanoma treatment options.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
12.2K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.1K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K